Mundipharma
Alice Pipponzi is a seasoned talent development and acquisition professional with extensive experience in leading global talent strategies. Currently serving as Senior Manager of Talent Development and Acquisition at Mundipharma, Alice previously held various roles at AstraZeneca, including Global Talent Strategy Lead, where Alice spearheaded the design and implementation of global talent standards and development initiatives. Recognized for excellence in talent management, Alice has been shortlisted for the CIPD Award and has won the Brandon Hall Award. Additional experience includes leading talent management for the Italian Marketing Company and managing digital talent strategies as the Global Product Owner of the Workday Talent Module. Alice's recruitment expertise was further developed at LoveWorkLife Recruitment, focusing on talent acquisition for General Motors subsidiaries. Alice holds a Master's degree in Italian Studies and Bachelor's degree in Modern Philology from prestigious Italian institutions.
This person is not in any teams
This person is not in any offices
Mundipharma
5 followers
The Mundipharma global network of independent associated companies shares a common purpose to identify and accelerate the development of meaningful medicines that add value for patients and healthcare providers around the globe. Founded in the US by two physicians in 1952 and still privately owned, the network has a presence in over 120 countries. In Europe, the network employees more than 2,000 employees from R&D to manufacturing & supply and commercial, and with revenues in excess of €1 billion. At Mundipharma we strive for one high performing and learning environment where individuals can make a real difference. We have a strong track record of building successful alliances to license, develop and market medicines that improve patients’ lives, while also providing attractive options to financially constrained healthcare systems. Consistent with our entrepreneurial heritage, we like to think that we see what others don’t by challenging conventional wisdom and asking different and challenging questions. By working in partnership with all our stakeholders, the Mundipharma network develops medicines that create value for patients, payers and wider healthcare systems. We have built a European portfolio of medicines to create value for patients, payers and wider healthcare systems across important therapeutic areas such as diabetes, respiratory, oncology, pain and biosimilars.